nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0273	0.111	CbGeAlD
Ketoprofen—CXCR1—adipose tissue—polycystic ovary syndrome	0.0259	0.105	CbGeAlD
Ketoprofen—SLC22A8—urine—polycystic ovary syndrome	0.0202	0.0816	CbGeAlD
Ketoprofen—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.0177	0.138	CcSEcCtD
Ketoprofen—CYP2C9—urine—polycystic ovary syndrome	0.0131	0.0531	CbGeAlD
Ketoprofen—CXCL8—adrenal cortex—polycystic ovary syndrome	0.0114	0.0463	CbGeAlD
Ketoprofen—Mefenamic acid—AKR1C2—polycystic ovary syndrome	0.0102	0.285	CrCbGaD
Ketoprofen—CXCL8—endometrium—polycystic ovary syndrome	0.0102	0.0413	CbGeAlD
Ketoprofen—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0101	0.0783	CcSEcCtD
Ketoprofen—CXCL8—pituitary gland—polycystic ovary syndrome	0.00923	0.0374	CbGeAlD
Ketoprofen—CXCL8—adipose tissue—polycystic ovary syndrome	0.00919	0.0372	CbGeAlD
Ketoprofen—CXCL8—adrenal gland—polycystic ovary syndrome	0.00825	0.0334	CbGeAlD
Ketoprofen—CXCL8—female gonad—polycystic ovary syndrome	0.00769	0.0311	CbGeAlD
Ketoprofen—CXCL8—vagina—polycystic ovary syndrome	0.00764	0.031	CbGeAlD
Ketoprofen—SLC22A11—endocrine gland—polycystic ovary syndrome	0.00592	0.024	CbGeAlD
Ketoprofen—SLC22A7—endocrine gland—polycystic ovary syndrome	0.00578	0.0234	CbGeAlD
Ketoprofen—Mefenamic acid—AKR1C1—polycystic ovary syndrome	0.0056	0.156	CrCbGaD
Ketoprofen—Renal impairment—Metformin—polycystic ovary syndrome	0.00452	0.0351	CcSEcCtD
Ketoprofen—ABCC4—uterus—polycystic ovary syndrome	0.00443	0.0179	CbGeAlD
Ketoprofen—ABCC4—adipose tissue—polycystic ovary syndrome	0.00433	0.0175	CbGeAlD
Ketoprofen—Migraine—Metformin—polycystic ovary syndrome	0.00423	0.0329	CcSEcCtD
Ketoprofen—Bopindolol—ADRB3—polycystic ovary syndrome	0.00412	0.115	CrCbGaD
Ketoprofen—ALB—adrenal gland—polycystic ovary syndrome	0.00401	0.0163	CbGeAlD
Ketoprofen—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00393	0.0305	CcSEcCtD
Ketoprofen—ABCC4—adrenal gland—polycystic ovary syndrome	0.00388	0.0157	CbGeAlD
Ketoprofen—PTGS2—embryo—polycystic ovary syndrome	0.0037	0.015	CbGeAlD
Ketoprofen—Pancreatitis—Metformin—polycystic ovary syndrome	0.00364	0.0283	CcSEcCtD
Ketoprofen—ABCC4—female gonad—polycystic ovary syndrome	0.00362	0.0147	CbGeAlD
Ketoprofen—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.0035	0.0142	CbGeAlD
Ketoprofen—CYP2C8—endometrium—polycystic ovary syndrome	0.00349	0.0141	CbGeAlD
Ketoprofen—ABCC4—endocrine gland—polycystic ovary syndrome	0.00337	0.0136	CbGeAlD
Ketoprofen—Drowsiness—Metformin—polycystic ovary syndrome	0.00331	0.0258	CcSEcCtD
Ketoprofen—Mefenamic acid—AKR1C3—polycystic ovary syndrome	0.00325	0.0906	CrCbGaD
Ketoprofen—Naproxen—AKR1C3—polycystic ovary syndrome	0.00319	0.0889	CrCbGaD
Ketoprofen—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00316	0.0128	CbGeAlD
Ketoprofen—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00303	0.0123	CbGeAlD
Ketoprofen—Rhinitis—Metformin—polycystic ovary syndrome	0.00298	0.0232	CcSEcCtD
Ketoprofen—Hepatitis—Metformin—polycystic ovary syndrome	0.00297	0.0231	CcSEcCtD
Ketoprofen—Labetalol—ADRB3—polycystic ovary syndrome	0.00295	0.0821	CrCbGaD
Ketoprofen—PTGS1—endometrium—polycystic ovary syndrome	0.00283	0.0115	CbGeAlD
Ketoprofen—Flushing—Metformin—polycystic ovary syndrome	0.00276	0.0215	CcSEcCtD
Ketoprofen—PTGS2—endometrium—polycystic ovary syndrome	0.0027	0.011	CbGeAlD
Ketoprofen—Chills—Metformin—polycystic ovary syndrome	0.00267	0.0208	CcSEcCtD
Ketoprofen—CYP2C8—vagina—polycystic ovary syndrome	0.00261	0.0106	CbGeAlD
Ketoprofen—PTGS1—uterus—polycystic ovary syndrome	0.00261	0.0106	CbGeAlD
Ketoprofen—Erythema—Metformin—polycystic ovary syndrome	0.00259	0.0201	CcSEcCtD
Ketoprofen—PTGS1—pituitary gland—polycystic ovary syndrome	0.00256	0.0104	CbGeAlD
Ketoprofen—Flatulence—Metformin—polycystic ovary syndrome	0.00255	0.0198	CcSEcCtD
Ketoprofen—PTGS1—adipose tissue—polycystic ovary syndrome	0.00255	0.0103	CbGeAlD
Ketoprofen—Dysgeusia—Metformin—polycystic ovary syndrome	0.00254	0.0197	CcSEcCtD
Ketoprofen—PTGS2—uterus—polycystic ovary syndrome	0.00249	0.0101	CbGeAlD
Ketoprofen—PTGS2—pituitary gland—polycystic ovary syndrome	0.00245	0.00991	CbGeAlD
Ketoprofen—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00245	0.00991	CbGeAlD
Ketoprofen—PTGS2—adipose tissue—polycystic ovary syndrome	0.00244	0.00987	CbGeAlD
Ketoprofen—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0024	0.0187	CcSEcCtD
Ketoprofen—Malaise—Metformin—polycystic ovary syndrome	0.00234	0.0182	CcSEcCtD
Ketoprofen—Palpitations—Metformin—polycystic ovary syndrome	0.00229	0.0178	CcSEcCtD
Ketoprofen—PTGS1—adrenal gland—polycystic ovary syndrome	0.00229	0.00926	CbGeAlD
Ketoprofen—Hypertension—Metformin—polycystic ovary syndrome	0.00224	0.0174	CcSEcCtD
Ketoprofen—Myalgia—Metformin—polycystic ovary syndrome	0.0022	0.0171	CcSEcCtD
Ketoprofen—PTGS2—adrenal gland—polycystic ovary syndrome	0.00219	0.00885	CbGeAlD
Ketoprofen—Discomfort—Metformin—polycystic ovary syndrome	0.00218	0.0169	CcSEcCtD
Ketoprofen—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00217	0.0088	CbGeAlD
Ketoprofen—PTGS1—female gonad—polycystic ovary syndrome	0.00213	0.00864	CbGeAlD
Ketoprofen—PTGS1—vagina—polycystic ovary syndrome	0.00212	0.00859	CbGeAlD
Ketoprofen—Oedema—Metformin—polycystic ovary syndrome	0.00211	0.0164	CcSEcCtD
Ketoprofen—Infection—Metformin—polycystic ovary syndrome	0.0021	0.0163	CcSEcCtD
Ketoprofen—Shock—Metformin—polycystic ovary syndrome	0.00208	0.0162	CcSEcCtD
Ketoprofen—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00207	0.0161	CcSEcCtD
Ketoprofen—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00204	0.0159	CcSEcCtD
Ketoprofen—PTGS2—female gonad—polycystic ovary syndrome	0.00204	0.00826	CbGeAlD
Ketoprofen—PTGS2—vagina—polycystic ovary syndrome	0.00203	0.00821	CbGeAlD
Ketoprofen—Anorexia—Metformin—polycystic ovary syndrome	0.00201	0.0157	CcSEcCtD
Ketoprofen—PTGS1—endocrine gland—polycystic ovary syndrome	0.00198	0.00803	CbGeAlD
Ketoprofen—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00193	0.015	CcSEcCtD
Ketoprofen—Paraesthesia—Metformin—polycystic ovary syndrome	0.0019	0.0148	CcSEcCtD
Ketoprofen—PTGS2—endocrine gland—polycystic ovary syndrome	0.0019	0.00768	CbGeAlD
Ketoprofen—Dyspnoea—Metformin—polycystic ovary syndrome	0.00188	0.0147	CcSEcCtD
Ketoprofen—Somnolence—Metformin—polycystic ovary syndrome	0.00188	0.0146	CcSEcCtD
Ketoprofen—Dyspepsia—Metformin—polycystic ovary syndrome	0.00186	0.0145	CcSEcCtD
Ketoprofen—Decreased appetite—Metformin—polycystic ovary syndrome	0.00184	0.0143	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00182	0.0142	CcSEcCtD
Ketoprofen—Fatigue—Metformin—polycystic ovary syndrome	0.00182	0.0142	CcSEcCtD
Ketoprofen—Constipation—Metformin—polycystic ovary syndrome	0.00181	0.0141	CcSEcCtD
Ketoprofen—Modafinil—ADRA1B—polycystic ovary syndrome	0.0018	0.05	CrCbGaD
Ketoprofen—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00174	0.0135	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00173	0.0134	CcSEcCtD
Ketoprofen—Urticaria—Metformin—polycystic ovary syndrome	0.00168	0.0131	CcSEcCtD
Ketoprofen—Abdominal pain—Metformin—polycystic ovary syndrome	0.00167	0.013	CcSEcCtD
Ketoprofen—Bopindolol—ADRB2—polycystic ovary syndrome	0.00157	0.0436	CrCbGaD
Ketoprofen—Asthenia—Metformin—polycystic ovary syndrome	0.00152	0.0118	CcSEcCtD
Ketoprofen—Pruritus—Metformin—polycystic ovary syndrome	0.0015	0.0116	CcSEcCtD
Ketoprofen—Diarrhoea—Metformin—polycystic ovary syndrome	0.00145	0.0112	CcSEcCtD
Ketoprofen—Dizziness—Metformin—polycystic ovary syndrome	0.0014	0.0109	CcSEcCtD
Ketoprofen—Vomiting—Metformin—polycystic ovary syndrome	0.00134	0.0105	CcSEcCtD
Ketoprofen—Mebendazole—CYP1A1—polycystic ovary syndrome	0.00134	0.0374	CrCbGaD
Ketoprofen—Rash—Metformin—polycystic ovary syndrome	0.00133	0.0104	CcSEcCtD
Ketoprofen—Dermatitis—Metformin—polycystic ovary syndrome	0.00133	0.0104	CcSEcCtD
Ketoprofen—Headache—Metformin—polycystic ovary syndrome	0.00132	0.0103	CcSEcCtD
Ketoprofen—Nausea—Metformin—polycystic ovary syndrome	0.00126	0.00976	CcSEcCtD
Ketoprofen—Labetalol—ADRB2—polycystic ovary syndrome	0.00112	0.0312	CrCbGaD
Ketoprofen—Warfarin—CYP1A1—polycystic ovary syndrome	0.000752	0.0209	CrCbGaD
Ketoprofen—CXCR1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000121	0.000206	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000121	0.000206	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	0.000121	0.000206	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	0.000121	0.000206	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000121	0.000205	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	0.00012	0.000204	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TEAD2—polycystic ovary syndrome	0.00012	0.000204	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—SERPINE1—polycystic ovary syndrome	0.00012	0.000204	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.00012	0.000204	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00012	0.000203	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000119	0.000203	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PGR—polycystic ovary syndrome	0.000118	0.000201	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000118	0.000201	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000118	0.0002	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000116	0.000198	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000116	0.000197	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000116	0.000197	CbGpPWpGaD
Ketoprofen—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000115	0.000196	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000115	0.000196	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.000115	0.000196	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000115	0.000195	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000114	0.000193	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000113	0.000192	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000113	0.000192	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NAMPT—polycystic ovary syndrome	0.000113	0.000192	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000113	0.000191	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000112	0.000191	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000112	0.00019	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000111	0.000189	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000111	0.000189	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000111	0.000188	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000111	0.000188	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00011	0.000187	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00011	0.000187	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.00011	0.000187	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000108	0.000183	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000107	0.000182	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000106	0.00018	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000106	0.00018	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000105	0.000179	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000105	0.000179	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000105	0.000178	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000105	0.000178	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000104	0.000177	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000104	0.000176	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000102	0.000174	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000102	0.000174	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000102	0.000173	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000101	0.000172	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.000101	0.000171	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000101	0.000171	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.0001	0.000171	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.0001	0.00017	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	9.96e-05	0.000169	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	9.88e-05	0.000168	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	9.85e-05	0.000167	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	9.85e-05	0.000167	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NGFR—polycystic ovary syndrome	9.69e-05	0.000165	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—POMC—polycystic ovary syndrome	9.63e-05	0.000164	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	9.61e-05	0.000163	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PRL—polycystic ovary syndrome	9.61e-05	0.000163	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	9.59e-05	0.000163	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	9.58e-05	0.000163	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	9.56e-05	0.000162	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.47e-05	0.000161	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	9.47e-05	0.000161	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	9.32e-05	0.000158	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	9.29e-05	0.000158	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.27e-05	0.000158	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.26e-05	0.000157	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	9.17e-05	0.000156	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FGF18—polycystic ovary syndrome	9.17e-05	0.000156	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—STAR—polycystic ovary syndrome	9.12e-05	0.000155	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.11e-05	0.000155	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	9.11e-05	0.000155	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RBP4—polycystic ovary syndrome	9.09e-05	0.000154	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.06e-05	0.000154	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.01e-05	0.000153	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—TH—polycystic ovary syndrome	8.98e-05	0.000153	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.98e-05	0.000153	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	8.95e-05	0.000152	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—GNAS—polycystic ovary syndrome	8.84e-05	0.00015	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—LHB—polycystic ovary syndrome	8.74e-05	0.000148	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—SLC2A4—polycystic ovary syndrome	8.74e-05	0.000148	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	8.6e-05	0.000146	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.55e-05	0.000145	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	8.54e-05	0.000145	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	8.49e-05	0.000144	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GNAS—polycystic ovary syndrome	8.45e-05	0.000144	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.43e-05	0.000143	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—GAB1—polycystic ovary syndrome	8.37e-05	0.000142	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	8.27e-05	0.000141	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—VEGFA—polycystic ovary syndrome	8.26e-05	0.00014	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	8.25e-05	0.00014	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP19A1—polycystic ovary syndrome	8.21e-05	0.00014	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	8.17e-05	0.000139	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NAMPT—polycystic ovary syndrome	8.15e-05	0.000139	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HMMR—polycystic ovary syndrome	8.13e-05	0.000138	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.05e-05	0.000137	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	8.02e-05	0.000136	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.92e-05	0.000135	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRG1—polycystic ovary syndrome	7.9e-05	0.000134	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	7.9e-05	0.000134	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	7.82e-05	0.000133	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	7.8e-05	0.000132	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	7.75e-05	0.000132	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.71e-05	0.000131	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.66e-05	0.00013	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.65e-05	0.00013	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	7.61e-05	0.000129	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	7.6e-05	0.000129	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	7.48e-05	0.000127	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	7.46e-05	0.000127	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.38e-05	0.000125	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	7.37e-05	0.000125	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	7.33e-05	0.000125	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.31e-05	0.000124	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.26e-05	0.000123	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	7.25e-05	0.000123	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	7.11e-05	0.000121	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	7.11e-05	0.000121	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—LHB—polycystic ovary syndrome	7.07e-05	0.00012	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	6.98e-05	0.000119	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	6.95e-05	0.000118	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	6.91e-05	0.000117	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—TH—polycystic ovary syndrome	6.83e-05	0.000116	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	6.83e-05	0.000116	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.79e-05	0.000115	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IRS2—polycystic ovary syndrome	6.77e-05	0.000115	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	6.74e-05	0.000115	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	6.73e-05	0.000114	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.69e-05	0.000114	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	6.69e-05	0.000114	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	6.65e-05	0.000113	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	6.65e-05	0.000113	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—LEP—polycystic ovary syndrome	6.62e-05	0.000113	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	6.62e-05	0.000112	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	6.41e-05	0.000109	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	6.37e-05	0.000108	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	6.35e-05	0.000108	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	6.3e-05	0.000107	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.27e-05	0.000107	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	6.27e-05	0.000106	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	6.25e-05	0.000106	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	6.19e-05	0.000105	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	6.17e-05	0.000105	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	6.16e-05	0.000105	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PRL—polycystic ovary syndrome	6.01e-05	0.000102	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	6e-05	0.000102	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—RRM2—polycystic ovary syndrome	5.96e-05	0.000101	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.95e-05	0.000101	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IRS1—polycystic ovary syndrome	5.91e-05	0.0001	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	5.79e-05	9.83e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	5.78e-05	9.82e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—YAP1—polycystic ovary syndrome	5.75e-05	9.77e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IGF1—polycystic ovary syndrome	5.72e-05	9.72e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT2—polycystic ovary syndrome	5.72e-05	9.71e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—POMC—polycystic ovary syndrome	5.69e-05	9.67e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—INS—polycystic ovary syndrome	5.66e-05	9.61e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	5.66e-05	9.61e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	5.58e-05	9.48e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	5.56e-05	9.44e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NAMPT—polycystic ovary syndrome	5.52e-05	9.38e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.52e-05	9.38e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.49e-05	9.33e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	5.49e-05	9.32e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL6—polycystic ovary syndrome	5.48e-05	9.31e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	5.48e-05	9.31e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF1—polycystic ovary syndrome	5.47e-05	9.3e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT2—polycystic ovary syndrome	5.47e-05	9.29e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	5.45e-05	9.27e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.45e-05	9.25e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	5.43e-05	9.23e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TH—polycystic ovary syndrome	5.42e-05	9.21e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.42e-05	9.2e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	5.31e-05	9.03e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	5.28e-05	8.96e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.2e-05	8.83e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	5.18e-05	8.8e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	5.15e-05	8.75e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	5.1e-05	8.67e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	5.07e-05	8.62e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	5.04e-05	8.56e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	5.04e-05	8.56e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NCOR1—polycystic ovary syndrome	5.04e-05	8.56e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	5.01e-05	8.5e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	4.96e-05	8.43e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRG1—polycystic ovary syndrome	4.94e-05	8.4e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	4.94e-05	8.39e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	4.91e-05	8.34e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	4.88e-05	8.29e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	4.71e-05	7.99e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	4.7e-05	7.98e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	4.52e-05	7.68e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.49e-05	7.64e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	4.47e-05	7.59e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MTHFR—polycystic ovary syndrome	4.45e-05	7.56e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.43e-05	7.53e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	4.43e-05	7.52e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TH—polycystic ovary syndrome	4.41e-05	7.5e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TH—polycystic ovary syndrome	4.39e-05	7.45e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	4.29e-05	7.29e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	4.27e-05	7.25e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IRS2—polycystic ovary syndrome	4.23e-05	7.19e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	4.22e-05	7.17e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.22e-05	7.16e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL6—polycystic ovary syndrome	4.19e-05	7.11e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.15e-05	7.05e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	4.04e-05	6.86e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	4.01e-05	6.82e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	4e-05	6.79e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	3.81e-05	6.47e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—POMC—polycystic ovary syndrome	3.76e-05	6.38e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	3.74e-05	6.35e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—INS—polycystic ovary syndrome	3.73e-05	6.34e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	3.73e-05	6.33e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IRS1—polycystic ovary syndrome	3.7e-05	6.28e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	3.6e-05	6.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.59e-05	6.1e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNAS—polycystic ovary syndrome	3.58e-05	6.09e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.58e-05	6.07e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—INS—polycystic ovary syndrome	3.54e-05	6.01e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.49e-05	5.94e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	3.43e-05	5.83e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT2—polycystic ovary syndrome	3.42e-05	5.81e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NCOR1—polycystic ovary syndrome	3.41e-05	5.8e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.29e-05	5.58e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	3.25e-05	5.53e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	3.25e-05	5.52e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.24e-05	5.5e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	3.03e-05	5.15e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	3.02e-05	5.14e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—MTHFR—polycystic ovary syndrome	3.02e-05	5.12e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—POMC—polycystic ovary syndrome	2.98e-05	5.06e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—INS—polycystic ovary syndrome	2.96e-05	5.04e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.93e-05	4.98e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.79e-05	4.75e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.65e-05	4.5e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL6—polycystic ovary syndrome	2.47e-05	4.2e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.47e-05	4.19e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	2.46e-05	4.18e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.45e-05	4.15e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	2.43e-05	4.12e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—INS—polycystic ovary syndrome	2.41e-05	4.1e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—POMC—polycystic ovary syndrome	2.41e-05	4.1e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—INS—polycystic ovary syndrome	2.4e-05	4.08e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2e-05	3.4e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.97e-05	3.35e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.96e-05	3.34e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IL6—polycystic ovary syndrome	1.55e-05	2.63e-05	CbGpPWpGaD
